Cowen And Company »

Urogen Pharma shares owned by Cowen And Company

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by Cowen And Company from 13F filings

Historical chart of Cowen And Company investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by Cowen And Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by Cowen And Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $24M 1.6M 15.00

More positions owned by Cowen And Company

NVIDIA Corporation (NVDA)
Coinbase Global Com Cl A (COIN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Avidity Biosciences Ord (RNA)
Meta Platforms Cl A (META)
Ishares Tr Msci Emg Mkt Etf (EEM)
Ptc Therapeutics I (PTCT)
Tarsus Pharmaceuticals (TARS)
Quanta Services (PWR)
Establishment Labs Holdings Ord (ESTA)
Stoke Therapeutics (STOK)
Protagonist Therapeutics (PTGX)
Apple (AAPL)
Fulcrum Therapeutics (FULC)
Sumitomo Mitsui Finl Group I Sponsored Adr (SMFG)

View all positions for Cowen And Company

Top funds holding Urogen Pharma

RA Capital Management
Dr. Jeffrey R. Jay, M.D.
Menora Mivtachim Holdings
BlackRock
Cowen And Company
Adage Capital Partners GP
Credit Suisse
Point72 Asset Management
Leucadia National Corporation
Migdal Insurance & Financial Holdings
Harel Insurance Investments & Financial Services
Morgan Stanley
Geode Capital Management
Superstring Capital Management
Opaleye Management

View all funds holding Urogen Pharma